Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLATINUM: Plegridy Satisfaction in RRMS
NCT02587065Phase 4Completed
- Sponsor
- Biogen
- Start
- Feb 2016
- Primary completion
- Oct 2017
- Modality
- Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon beta in relapsing-remitting multiple sclerosis (RRMS), sponsored by Biogen. Started Feb 2016; status: completed.
02
Drugs
interferon beta
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT02587065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587065.